Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,007 public trials 2,555 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

NCT05150691

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +45 more
Locations
  • Helios Clinical Research Cerritos, California, United States
  • California Research Institute Los Angeles, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 102 locations
View Trial Details
Recruiting

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

NCT07050433

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Rogel Cancer Center Ann Arbor, Michigan, United States
  • Duke University Durham, North Carolina, United States
  • University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
View Trial Details
Recruiting

Endometrial Cancer Vaginal Fluid Specimen Collection Study

NCT07544680

Conditions
Abnormal Uterine Bleeding (AUB), Atypical Endometrial Hyperplasia, Endometrial Cancer, +21 more
Locations
  • Murfreesboro Medical Clinic Murfreesboro, Tennessee, United States
  • Physical Care Clinical Research Sarasota, Florida, United States
  • MaineHealth Scarborough, Maine, United States
  • IC Research Murfreesboro, Tennessee, United States
View Trial Details
Recruiting

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

NCT05281471

Conditions
Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
Locations
  • The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • UC San Diego Health - Moores Cancer Center La Jolla, California, United States
View all 33 locations
View Trial Details
Recruiting

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

NCT07611110

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Research Site Dothan, Alabama, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
View all 132 locations
View Trial Details
Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

NCT07383506

Conditions
Advanced Solid Tumors, Adult, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Washington University School of Medicine - Siteman Cancer Center St Louis, Missouri, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Virginia Fairfax, Virginia, United States
View Trial Details

Related conditions